Sivik Global Healthcare LLC Boosts Holdings in Humana Inc. (NYSE:HUM)

Sivik Global Healthcare LLC boosted its position in shares of Humana Inc. (NYSE:HUM) by 33.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,000 shares of the insurance provider’s stock after purchasing an additional 2,500 shares during the period. Sivik Global Healthcare LLC’s holdings in Humana were worth $3,167,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HUM. CarsonAllaria Wealth Management Ltd. raised its stake in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Creative Financial Designs Inc. ADV lifted its stake in Humana by 244.0% during the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares during the last quarter. Atwood & Palmer Inc. acquired a new position in Humana in the third quarter worth $29,000. Hantz Financial Services Inc. bought a new stake in Humana during the second quarter valued at $35,000. Finally, Family Firm Inc. acquired a new stake in shares of Humana during the second quarter worth $37,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on HUM shares. Wells Fargo & Company decreased their target price on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. Oppenheimer dropped their target price on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. UBS Group reduced their price target on shares of Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, October 4th. Royal Bank of Canada cut their price objective on shares of Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Finally, Stephens reaffirmed an “equal weight” rating and set a $250.00 price target on shares of Humana in a report on Wednesday, October 9th. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $315.86.

Humana Trading Down 2.3 %

HUM traded down $6.73 during mid-day trading on Thursday, reaching $282.69. The stock had a trading volume of 222,244 shares, compared to its average volume of 1,866,385. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18. The stock has a market capitalization of $34.04 billion, a P/E ratio of 25.67, a P/E/G ratio of 2.21 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The firm’s fifty day simple moving average is $284.64 and its two-hundred day simple moving average is $332.14.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. On average, equities analysts predict that Humana Inc. will post 15.83 EPS for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.25%. Humana’s dividend payout ratio is 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.